Jump to content

Definition:Cost of capital method

From Insurer Brain
Revision as of 19:50, 16 March 2026 by PlumBot (talk | contribs) (Bot: Creating new article from JSON)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

📐 Cost of capital method is a valuation and reserving technique used in insurance to quantify the risk margin — the additional amount, over and above the best estimate of liabilities, that a rational insurer would require as compensation for bearing the uncertainty inherent in those obligations. The method is most closely associated with Solvency II, where it serves as the prescribed approach for calculating the risk margin component of technical provisions, but variants appear in Switzerland's SST, in the Bermuda regulatory framework under the BMA, and in actuarial practice more broadly when determining the fair value of insurance liabilities for transactions or financial reporting.

⚙️ Under Solvency II, the cost of capital method works by projecting the solvency capital requirement that a hypothetical entity — one that assumes the insurer's obligations — would need to hold in each future year until all liabilities are settled. A fixed cost-of-capital rate (set by EIOPA at 6% per annum, though periodically debated in regulatory reviews) is then applied to each year's projected SCR, and the resulting stream of annual costs is discounted back to the valuation date. The sum of those discounted costs is the risk margin. In practice, projecting future SCRs for every year of run-off can be computationally demanding, especially for long-tail lines such as liability or life insurance. EIOPA permits simplified approaches — including proportional methods, duration-based approximations, and hierarchies of simplifications — that allow insurers to estimate the risk margin without a full SCR recalculation at each future time step. Under IFRS 17, the cost of capital approach is one of several acceptable methods for determining the risk adjustment for non-financial risk, though the standard does not mandate a specific rate.

💡 Debate around the cost of capital method has intensified in recent years, particularly regarding whether the prescribed rate adequately reflects market conditions and whether the method produces risk margins that are excessively large for long-duration liabilities. A high risk margin increases an insurer's total technical provisions, reducing own funds and potentially constraining the capacity to write new business — a concern raised especially by life insurers and annuity providers with obligations stretching decades into the future. The 2020 Solvency II review addressed some of these criticisms by introducing adjustments designed to dampen the risk margin's sensitivity to interest rate movements. Beyond regulation, the cost of capital method also informs real-world transactions: when one insurer acquires a run-off portfolio from another, the risk margin calculated via this method often forms a key component of the transfer price, reflecting the capital cost the acquirer will bear until the liabilities are fully extinguished.

Related concepts: